Intellectual Disability in Episodic Ataxia Type 2: Beyond Paroxysmal Vertigo and Ataxia
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Purpose Episodic ataxia type 2 (EA2) is characterized by recurrent vertigo and ataxia due to mutations in CACNA1A that encodes the α1A-subunit of the P/Q-type voltage-gated calcium channel. This study aimed to determine intellectual function in EA2. Methods During 2019–2023, 13 patients (6 males, age range=10–52 years, median age=29 years) with a genetically confirmed diagnosis of EA2 had their intellectual function evaluated using the Korean versions of the Wechsler Intelligence Scales (version IV) for adults or children in 3 referral-based university hospitals in South Korea. Results The full-scale intelligence quotients (FSIQs) among the 13 patients were below the average (90–109) in 11, low average (80–89) in 5 (38.5%), borderline (70–79) in 1 (7.7%), and indicated intellectual disability (≤69) in 5 (38.5%). These patterns of cognitive impairments were observed in all four of the following subtests: verbal comprehension, perceptual reasoning, working memory, and processing speed. The FSIQ was not correlated with the ages at onset for vertigo and ataxia (Pearson correlation: p=0.40). Conclusions Patients with EA2 may have hidden intellectual disabilities even without a history of epilepsy or administration of antiepileptic drugs, and should be considered for genetic counseling and therapeutic interventions. Given the availability of medication to control episodic vertigo and ataxia, early diagnosis and management are important in preventing irreversible brain dysfunction in EA2.
Abstract
Background and Purpose Episodic ataxia type 2 (EA2) is characterized by recurrent vertigo and ataxia due to mutations in CACNA1A that encodes the α1A-subunit of the P/Q-type voltage-gated calcium channel. This study aimed to determine intellectual function in EA2. Methods During 2019–2023, 13 patients (6 males, age range=10–52 years, median age=29 years) with a genetically confirmed diagnosis of EA2 had their intellectual function evaluated using the Korean versions of the Wechsler Intelligence Scales (version IV) for adults or children in 3 referral-based university hospitals in South Korea. Results The full-scale intelligence quotients (FSIQs) among the 13 patients were below the average (90–109) in 11, low average (80–89) in 5 (38.5%), borderline (70–79) in 1 (7.7%), and indicated intellectual disability (≤69) in 5 (38.5%). These patterns of cognitive impairments were observed in all four of the following subtests: verbal comprehension, perceptual reasoning, working memory, and processing speed. The FSIQ was not correlated with the ages at onset for vertigo and ataxia (Pearson correlation: p=0.40). Conclusions Patients with EA2 may have hidden intellectual disabilities even without a history of epilepsy or administration of antiepileptic drugs, and should be considered for genetic counseling and therapeutic interventions. Given the availability of medication to control episodic vertigo and ataxia, early diagnosis and management are important in preventing irreversible brain dysfunction in EA2.
참고문헌 (71)
- Jen JC, "Primary episodic ataxias : diagnosis, pathogenesis and treatment", Brain, 130, pp.2484~2493 (2007)
- Jen J, "Clinical spectrum of episodic ataxia type 2", Neurology, 62, pp.17~22 (2004)
- Griggs RC, "Hereditary paroxysmal ataxia : response to acetazolamide", Neurology, 28, pp.1259~1264 (1978)
- Strupp M, "Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine", Neurology, 62, pp.1623~1625 (2004)
- Ophoff RA, "Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4", Cell, 87, pp.543~552 (1996)
- Kim JM, "Episodic ataxia type 2 due to a deletion mutation in the CACNA1A gene in a Korean family", J Clin Neurol, 2, pp.268~271 (2006)
- Zhuchenko O, "Autosomal dominant cerebellar ataxia(SCA6)associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel", Nat Genet, 15, pp.62~69 (1997)
- Jouvenceau A, "Human epilepsy associated with dysfunction of the brain P", Q-type calcium channel, 2001, pp.358, 801~807
- Spacey SD, "Two novel CACNA1A gene mutations associated with episodic ataxia type 2 and interictal dystonia", Arch Neurol, 62, pp.314~316 (2005)
- Jen J, "A novel nonsense mutation in CACNA1A causes episodic ataxia and hemiplegia", Neurology, 53, pp.34~37 (1999)
- Ducros A, "The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel", N Engl J Med, 345, pp.17~24 (2001)
- Baloh RW, "Familial episodic ataxia : clinical heterogeneity in four families linked to chromosome 19p", Ann Neurol, 41, pp.8~16 (1997)
- Jodice C, "Episodic ataxia type 2(EA2)and spinocerebellar ataxia type 6(SCA6)due to CAG repeat expansion in the CACNA1A gene on chromosome 19p", Hum Mol Genet, 6, pp.1973~1978 (1997)
- Yue Q, "Progressive ataxia due to a missense mutation in a calcium-channel gene", Am J Hum Genet, 61, pp.1078~1087 (1997)
- Kipfer S, "Novel CACNA1A mutation(s)associated with slow saccade velocities", J Neurol, 260, pp.3010~3014 (2013)
- Rucker JC, "Internuclear ophthalmoparesis in episodic ataxia type 2", Ann N Y Acad Sci, 1039, pp.571~574 (2005)
- Kim S, "Vertical saccadic slowing in episodic ataxia type 2", J Clin Neurol, 18, pp.726~728 (2022)
- Jung J, "Phenotypic variability of episodic ataxia type 2 mutations : a family study", Eur Neurol, 64, pp.114~116 (2010)
- Park D, "A novel CACNA1A mutation associated with episodic ataxia 2 presenting with periodic paralysis", Acta Neurol Belg, 118, pp.137~139 (2018)
- Rajakulendran S, "Genetic and functional characterisation of the P", Q calcium channel in episodic ataxia with epilepsy, 2010, pp.588, 1905~1913
- Shimmura M, "Slowed abduction during smooth pursuit eye movement in episodic ataxia type 2 with a novel CACNA1A mutation", J Neurol Sci, 381, pp.4~6 (2017)
- Verriello L, "Epilepsy and episodic ataxia type 2 : family study and review of the literature", J Neurol, 268, pp.4296~4302 (2021)
- Indelicato E, "From genotype to phenotype : expanding the clinical spectrum of CACNA1A variants in the era of next generation sequencing", Front Neurol, 12, pp.639994~ (2021)
- Kim HJ, "Rebound upbeat nystagmus after lateral gaze in episodic ataxia type 2", Cerebellum, 13, pp.411~413 (2014)
- Choi JH, "Vestibular impairments in episodic ataxia type 2", J Neurol, 269, pp.2687~2695 (2022)
- Choi KD, "Genetic variants associated with episodic ataxia in Korea", Sci Rep, 7, pp.13855~ (2017)
- Choi KD, "Recovery of vestibular imbalances after vestibular neuritis", Laryngoscope, 117, pp.1307~1312 (2007)
- Lee SH, "Benign paroxysmal positional vertigo", J Clin Neurol, 6, pp.51~63 (2010)
- Halmagyi GM, "A clinical sign of canal paresis", Arch Neurol, 45, pp.737~739 (1988)
- Huh YE, "Bedside evaluation of dizzy patients", J Clin Neurol, 9, pp.203~213 (2013)
- Choi JY, "Central paroxysmal positional nystagmus : characteristics and possible mechanisms", Neurology, 84, pp.2238~2246 (2015)
- Lee SU, "Recurrent spontaneous vertigo with interictal headshaking nystagmus", Neurology, 90, pp.e2135~e2145 (2018)
- Yang Y, "Cerebellar hypoperfusion during transient global amnesia : an MRI and oculographic study", J Clin Neurol, 5, pp.74~80 (2009)
- Lee SU, "Lower brainstem melanocytoma masquerading as vestibular paroxysmia", J Neurol, 265, pp.1222~1225 (2018)
- Lee SU, "Evolution in the findings of head-impulse tests during the attacks of menière’s disease", Otol Neurotol, 41, pp.e744~e750 (2020)
- Wechsler D, "Wechsler Adult Intelligence Scale–Fourth Edition(WAISIV)" (2008), NCS Pearson
- Jung EJ, "Validity of the K-WAIS-IV short forms : focused on clinical utility", Clin Psychol Korea Res Pract, 5, pp.213~231 (2019)
- Choi KD, "Possible anticipation associated with a novel splice site mutation in episodic ataxia type 2", Neurol Sci, 34, pp.1629~1632 (2013)
- Jeon S, "Korean Genome Project: 1094 Korean personal genomes with clinical information", Sci Adv, 6, pp.eaaz7835~ (2020)
- Sim NL, "SIFT web server : predicting effects of amino acid substitutions on proteins", Nucleic Acids Res, 40(W1), pp.W452~W457 (2012)
- Adzhubei IA, "A method and server for predicting damaging missense mutations", Nat Methods, 7, pp.248~249 (2010)
- Steinhaus R, "MutationTaster2021", Nucleic Acids Res, 49(W1), pp.W446~W451 (2021)
- Davydov EV, "Identifying a high fraction of the human genome to be under selective constraint using GERP++", PLoS Comput Biol, 6, pp.e1001025~ (2010)
- Shevell M, "Practice parameter : evaluation of the child with global developmental delay : report of the Quality Standards Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society", Neurology, 60, pp.367~380 (2003)
- Ilyas M, "The genetics of intellectual disability : advancing technology and gene editing", F1000Res, 9(F1000 Faculty Rev), pp.22~ (2020)
- Ka M, "Essential roles for ARID1B in dendritic arborization and spine morphology of developing pyramidal neurons", J Neurosci, 36, pp.2723~2742 (2016)
- Mintz IM, "Calcium control of transmitter release at a cerebellar synapse", Neuron, 15, pp.675~688 (1995)
- Burgess DL, "Voltage-dependent calcium channel mutations in neurological disease", Ann N Y Acad Sci, 868, pp.199~212 (1999)
- Jen J, "Calcium channelopathies in the central nervous system", Curr Opin Neurobiol, 9, pp.274~280 (1999)
- Missiaen L, "Abnormal intracellular ca(2+)homeostasis and disease", Cell Calcium, 28, pp.1~21 (2000)
- Clapham DE, "Calcium signaling", Cell, 131, pp.1047~1058 (2007)
- Mallmann RT, "Ablation of Ca(V)2. 1 voltage-gated Ca(2+)channels in mouse forebrain generates multiple cognitive impairments", PLoS One, 8, pp.e78598~ (2013)
- Bohne P, "Cognitive deficits in episodic ataxia type 2 mouse models", Hum Mol Genet, 30, pp.1811~1832 (2021)
- Denier C, "High prevalence of CACNA1A truncations and broader clinical spectrum in episodic ataxia type 2", Neurology, 52, pp.1816~1821 (1999)
- Feeney GF, "Paroxysmal cerebellar ataxia", Aust N Z J Med, 19, pp.113~117 (1989)
- Hawkes CH, "Familial paroxysmal ataxia : report of a family", J Neurol Neurosurg Psychiatry, 55, pp.212~213 (1992)
- Vahedi K, "A gene for hereditary paroxysmal cerebellar ataxia maps to chromosome 19p", Ann Neurol, 37, pp.289~293 (1995)
- van den Maagdenberg AM, "Episodic ataxia type 2. Three novel truncating mutations and one novel missense mutation in the CACNA1A gene", J Neurol, 249, pp.1515~1519 (2002)
- Mochizuki Y, "Hereditary paroxysmal ataxia with mental retardation : a clinicopathological study in relation to episodic ataxia type 2", Acta Neuropathol, 108, pp.345~349 (2004)
- Guerin AA, "Stepwise developmental regression associated with novel CACNA1A mutation", Pediatr Neurol, 39, pp.363~364 (2008)
- Vahedi K, "CACNA1A gene de novo mutation causing hemiplegic migraine, coma, and cerebellar atrophy", Neurology, 55, pp.1040~1042 (2000)
- Nachbauer W, "Episodic ataxia type 2 : phenotype characteristics of a novel CACNA1A mutation and review of the literature", J Neurol, 261, pp.983~991 (2014)
- Damaj L, "CACNA1A haploinsufficiency causes cognitive impairment, autism and epileptic encephalopathy with mild cerebellar symptoms", Eur J Hum Genet, 23, pp.1505~1512 (2015)
- Hommersom MP, "The complexities of CACNA1A in clinical neurogenetics", J Neurol, 269, pp.3094~3108 (2022)
- Lipman AR, "Clinical and genetic characterization of CACNA1A-related disease", Clin Genet, 102, pp.288~295 (2022)
- Schmahmann JD, "The cerebellum and cognition", Neurosci Lett, 688, pp.62~75 (2019)
- Van Overwalle F, "Consensus paper : cerebellum and social cognition", Cerebellum, 19, pp.833~868 (2020)
- Jacobi H, "Update cerebellum and cognition", J Neurol, 268, pp.3921~3925 (2021)
- Sokolov AA, "The cerebellum : adaptive prediction for movement and cognition", Trends Cogn Sci, 21, pp.313~332 (2017)
- Bigelow RT, "Association between vertigo, cognitive and psychiatric conditions in US children : 2012 National Health Interview Survey", Int J Pediatr Otorhinolaryngol, 130, pp.109802~ (2020)
- Spacey SD, "Functional implications of a novel EA2 mutation in the P", Q-type calcium channel, 2004, pp.56, 213~220
